stem cell treatments, bionic vision devices, and intelligent eyewear have been evaluated for addressing vision issues, yet these methods can be quite invasive and costly. Earlier this year, the U.S. Food and Drug Administration greenlighted a novel option: Vizz, a prescription eye drop from LENZ Therapeutics that constricts your pupils to assist in focusing on nearby items without impairing your general vision.
Vizz has received FDA approval and became accessible in the United States last month, with broader usage anticipated to commence by early 2026. It has been promoted as a remedy for presbyopia for individuals who prefer to avoid glasses or contact lenses, and it has gone through thorough clinical trials to confirm its effectiveness and safety. While it is not a definitive solution for the condition since daily reapplication is necessary and it might not be suitable for everyone with specific ailments or sensitivities, it presents a compelling alternative to glasses for those who can utilize it.
